Innate Pharma
(IPHYF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 12-2023 | 06-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,965 | 71,847 | 76,416 | 77,870 | 88,739 |
| Marketable Securities | 7,178 | 15,554 | 23,649 | 19,055 | 18,185 |
| Receivables | 5,620 | 5,380 | 60,129 | 60,589 | 40,401 |
| Other current assets | 0 | 0 | -1 | 0 | 1 |
| TOTAL | $73,763 | $92,781 | $160,193 | $157,514 | $147,326 |
| Non-Current Assets | |||||
| PPE Net | 5,625 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 26,113 | 21,841 | 32,316 | 51,613 | 62,679 |
| TOTAL | $31,738 | $21,841 | $32,316 | $51,613 | $62,679 |
| Total Assets | $105,502 | $120,177 | $199,352 | $217,043 | $219,005 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,669 | 17,321 | 18,419 | 20,708 | 22,032 |
| Other current liabilities | 19,096 | 18,369 | 24,481 | 20,364 | 21,522 |
| TOTAL | $33,404 | $35,690 | $42,899 | $41,072 | $43,554 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 639 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 63,275 | 71,871 | 85,535 | 95,812 | 101,024 |
| TOTAL | $66,258 | $74,928 | $100,280 | $112,875 | $118,397 |
| Total Liabilities | $99,663 | $110,618 | $143,180 | $153,948 | $161,951 |
| Shareholders' Equity | |||||
| Common Shares | 5,233 | 4,536 | 4,377 | 4,391 | 4,226 |
| Retained earnings | -438,600 | -364,552 | -356,426 | -360,176 | -286,804 |
| Other shareholders' equity | -22,874 | -53,503 | -7,658 | 3,031 | -60,355 |
| TOTAL | $5,840 | $9,559 | $56,172 | $63,094 | $57,053 |
| Total Liabilities And Equity | $105,502 | $120,177 | $199,352 | $217,042 | $219,004 |